FDA Inspection 793599 — Abryrx, Inc.
The FDA completed an inspection of Abryrx, Inc. on July 6, 2012 in Irvington, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 6, 2012
- Fiscal Year
- 2012
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Irvington, NY (United States)
Additional Details
Sponsor, Contract Research Organization